IOL Chemicals IOL Chemicals

X

Find the latest Drugs in Development and Pipeline Prospector News of Zydus Lifesciences.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Zydus Lifesciences
india-flag Flag
Country
Country
India
Address
Address
Zydus Corporate Park, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, Sarkhej - Gandhinagar Hwy, Ahmedabad, 382481
Telephone
Telephone
91 2262801310

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Rexigo (relugolix) is a nonpeptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors. It is launched in India for testosterone suppression in patients with advanced prostate cancer.


Lead Product(s): Relugolix

Therapeutic Area: Oncology Product Name: Rexigo

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable February 01, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Under the terms of the agreement, Zydus will assume full responsibility for the clinical development and commercialization for leuprolide injectable in the US market, and Daewoong will be responsible for the pre-clinical studies, production and supply of the product.


Lead Product(s): Leuprolide Acetate

Therapeutic Area: Oncology Product Name: Lupron Depot-Generic

Highest Development Status: ApprovedProduct Type: Peptide

Recipient: Daewoong Pharmaceutical

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement December 12, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Under the terms of this agreement, Zydus has granted Sun Pharma semi-exclusive rights to comarket an innovative drug, Rytstat (desidustat), first-of-its-kind oral treatment for anemia associated with Chronic Kidney Disease, in India.


Lead Product(s): Desidustat

Therapeutic Area: Hematology Product Name: Rytstat

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Sun Pharmaceutical Industries Limited

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement October 30, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Zituvio (Sitagliptin) tablets A is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.


Lead Product(s): Sitagliptin Phosphate

Therapeutic Area: Endocrinology Product Name: Zituvio

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 20, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

A fixed dose combination of vilanterol (adrenergic receptor beta-2 agonist), glycopyrrolate & fluticasone furoate is approved for the treatment of chronic obstructive pulmonary disease.


Lead Product(s): Vilanterol Trifenatate,Glycopyrronium Bromide,Fluticasone Furoate

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Undisclosed

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 13, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Indocin (indomethacin) suppositories is a nonsteroidal anti-inflammatory drug that is indicated for the treatment of moderate to severe rheumatoid arthritis.


Lead Product(s): Indomethacin

Therapeutic Area: Immunology Product Name: Indocin-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 03, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Plerixafor Injection is a hematopoietic stem cell mobilizer used in combination with granulocyte-colony stimulating factor in patients with non-Hodgkin's lymphoma or multiple myeloma.


Lead Product(s): Plerixafor

Therapeutic Area: Oncology Product Name: Mozobil-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 27, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Oxcarbazepine tablets produce blockade of voltage-sensitive sodium channels, resulting in stabilization of hyperexcited neural membranes, inhibition of repetitive neuronal firing, and diminution of propagation of synaptic impulses. It is indicated to treat partial seizures.


Lead Product(s): Oxcarbazepine

Therapeutic Area: Neurology Product Name: Trileptal-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 04, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Minocycline hydrochloride extended-release tablets is a member of the tetracycline class of antibiotics, a bacteriostatic that exerts its antimicrobial activity by inhibiting protein synthesis that is used for used for treatment of moderate to severe acne.


Lead Product(s): Minocycline Hydrochloride

Therapeutic Area: Dermatology Product Name: Minocycline Hydrochloride-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 19, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Varenicline Tablet, for oral use is a nicotinic receptor partial agonist that is FDA-approved for use as an aid to smoking cessation treatment and Chantix is a RFLAD.


Lead Product(s): Varenicline Tartrate

Therapeutic Area: Psychiatry/Psychology Product Name: Chantix-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 13, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY